Published online Aug 26, 2025. doi: 10.12998/wjcc.v13.i24.108115
Revised: April 23, 2025
Accepted: May 13, 2025
Published online: August 26, 2025
Processing time: 72 Days and 3.2 Hours
This letter discusses the critical yet underrecognized intersection of chronic renal insufficiency and Nocardia brasiliensis skin infection in the case reported by Zhang et al, emphasizing the diagnostic challenges and therapeutic complexities in the context of advanced age, comorbidities, and immunocompromised populations. The study’s strengths included its integration of immunological profiling and precision medicine, demonstrating that a tailored low-dose trimethoprim-sulfamethoxazole regimen with pharmacokinetic monitoring can improve outcomes in geriatric patients with chronic renal insufficiency while mitigating nephrotoxicity risks. However, its limitations included a single-case design, reliance on phenotypic diagnostics, and the lack of information regarding comorbidity interactions. The findings support the use of advanced molecular tools for rapid pathogen identification and identification of co-infection. Future studies should prioritize elucidating the synergistic effects of chronic kidney disease-uremia and immunosuppression on Nocardia colonization, developing biomarkers for early detection, and conducting global epidemiological studies in endemic regions. This case underscores the importance of interdisciplinary collaboration and innovative diagnostics to optimize management of nocardiosis in vulnerable populations.
Core Tip: This study highlights the interplay of chronic renal insufficiency and Nocardia brasiliensis infection in immunocompromised patients. A tailored low-dose sulfamethoxazole-trimethoprim regimen with pharmacokinetic monitoring improved outcomes in a geriatric patient. Future research needs advanced diagnostics, biomarker development, and global epidemiological studies.